EATG » News

The European AIDS Treatment Group is looking for a Financial Assistant

Type of contract: Half-time, temporary position with possibility for extension Location: Brussels, Belgium Reporting to: Executive Director Start date: As soon as possible The European AIDS Treatment Group is looking…

The European AIDS Treatment Group is looking for an Executive Director

Type of contract: Full-time, permanent contract Location: Brussels, Belgium Reporting to: Board of Directors Start date: As soon as possible in the range of October-December 2018 The European AIDS Treatment…

2nd Hep-C Community Summit: We are more than just patients

The European AIDS Treatment Group participates in the 2nd Hep-C Community Summit that takes place on the 18th of September in Lisbon. Organised by Correlation European Harm Reduction Network, the summit will…

Webinar: Patient Engagement on Medicines Research & Development

Join us for a webinar about patient engagement in the process of research and development of medicines on Thursday, September 6 from 18:00 to 19:15 CET.   Four European patient…

Open letter: UN General Assembly High Level Meeting on the fight against Tuberculosis

Few weeks before the UN General Assembly High Level Meeting on the fight against Tuberculosis, the EATG issues an open letter: 'As negotiations on the final declaration are now being…

ESTICOM: First from a series of community reports from EMIS 2017 is now online

A week ago the EATG co-chaired the satellite symposium "European surveys and trainings to improve MSM community health (ESTICOM)" at the 22nd International AIDS conference.  During this session we had…

The EATG welcomes the European Court of Justice decision to invalidate the patent extension of Truvada

Amsterdam, 26 July 2018   The European AIDS Treatment Group welcomes the landmark decision of the European Court of Justice confirming the invalidity of the patent extension (Supplementary Protection Certificate)…

EATG at the 22nd International AIDS conference: Catch up with the evidence and give our communities the services we need

Amsterdam, 23 July 2018   As an organisation led by people living with HIV/AIDS across Europe and Central Asia, working together with the several affected communities in the last 25…

AIDS 2018: Addressing research gaps identified by women living with HIV in Europe and Central Asia

We are pleased to invite you to join a side-meeting at the AIDS 2018 conference that will bring together community, clinicians and researchers to discuss research gaps related to women…

AIDS 2018: The programme and the presentations of the European Civil Society Forum booth in the Global Village

The EATG and AIDS Action Europe are co-hosting the European Civil Society Forum (booth 618) at the Global Village of the 22nd International AIDS Conference in Amsterdam. Organisations and activists…

Ageing with HIV conference outcomes: read watch and register to discuss

The EATG organised a conference titled ‘New challenges and unmet needs of people living and ageing with HIV/AIDS aged 18-50, Quality of Life and Preventive Healthcare’ from 3 to 6…

EATG’s new term as a member of the Civil Society Forum on Drugs (2018-2021)

This week the European AIDS Treatment Group participated in the first meeting of the new 3-year term of the Civil Society Forum on Drugs that took place in Brussels. The CSFD…

What is on the minds of PLHIV in Europe in terms of their long term health?

Results: Long term health perspectives of people living with HIV in Europe   The EATG in collaboration with Volle Maan Communicatie Bureau conducted a study titled ‘Long term health perspectives…

EHVA: a clinical trial for therapeutic vaccination for HIV is about to start

Today and tomorrow EATG is attending the European HIV Vaccine Alliance (EHVA) consortium meeting in Barcelona. The EATG is one of the 39 partners of the consortium that aims to develop…

Position on scaling up HIV self-testing and self-sampling

Just published - an opinion piece on scaling up HIV self-testing and self-sampling, by the HIV in Europe Initiative (a European civil society, policy makers, health professionals and public health…

A more social Europe needs a more robust Health Programme

The EU Civil Society Forum on HIV, TB and Hepatitis, gathering leading civil society organisations at the national and regional level in the EU and neighbouring countries, welcomes with caution the…

EATG 2017 annual report is out now

2017 was the year that marked 25 exciting years of HIV/AIDS activism for the European AIDS Treatment Group. A year working towards achieving our goals and objectives is condensed in…

Call for organisations and activists to present at the European NGO booth (world AIDS 2018 conference)

We are happy to invite organisations and activists in Europe and Central Asia to present, discuss, share and learn at European NGO booth at the world AIDS 2018 Amsterdam conference.…

EATG launches a report on access to HCV-related services in prison settings in Europe

Today, the European AIDS Treatment Group launches a report along with recommendations on access to HCV-related services in prison settings in Europe. At the same time, a pilot Spring European…

Civil society organizations come forth with a Joint Statement in advance of the 39th meeting of the Global Fund Board

With a joint statement addressed to the Global Fund, more than 40 international, regional and national organizations have voiced their deep concerns regarding Global Fund's eligibility policy and the limitations…

8 lessons learned at the European Harm Reduction Conference

The 4th European Harm Reduction Conference took place in Bucharest on 21-23 November, 2018. You can watch here a video report from the conference and read some important highlights.  

Russian HIV prevention group closes after fine under ‘foreign-agent’ law

A Russian nongovernmental organization focused on preventing the spread of the HIV virus that causes AIDS says it has closed its office in the Siberian region of Altai Krai because…

December 2018 issue of The Lancet HIV now online

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. It publishes translational, epidemiological, clinical, operational, and implementation…

CATIE: December 2018 issue of TreatmentUpdate now online

TreatmentUpdate is CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment. TreatmentUpdate 229: Anti-HIV agents, December 2018 issue is available here.  

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

Paris, 5 December 2018 – Six organisations, including Médecins Sans Frontières (MSF), have just appealed the European Patent Office’s September decision to uphold US pharmaceutical corporation Gilead Science’s patent on the…

New dangers emerge as cocaine, meth, and other stimulants overtake opioids

The brightly-colored trend lines on the projected chart rise and fall until suddenly, in 2015, they all begin to spike simultaneously, reaching new heights. This chart summarizes epidemics of cocaine,…

The silent epidemic killing more people than HIV, malaria or TB

Viral hepatitis is on the rise. Tackling hepatitis B in Africa is key to fighting back. An article, published in Nature, examines global hepatitis B burden, death toll.  

Investigators discover compounds that block reactivation of latent HIV-1

Washington, DC - December 3, 2018 - A team of investigators from the University of Pittsburgh has identified compounds that block the reactivation of latent HIV-1 in a human cell…

Digital health services highly effective in early infant diagnosis of HIV in Kenya

A digital health system combining online services with text messages is highly effective in early infant diagnosis of HIV according to findings from a cluster-randomised controlled trial in Kenya published…

Europe’s hepatitis challenge

New TAG report: Funding for TB research climbed to new high in 2017

December 3, 2018 – Global funding for tuberculosis (TB) research climbed to a previously unreported high of USD $772 million in 2017, according to a report released today by Treatment…

Canada: Justice Department issues new guidelines on prosecution for non-disclosure of HIV status

Use of criminal law against people with HIV has been overly broad, Canadian HIV/AIDS Legal Network says. Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, says he's very…

CD4 count recovery: French study reaffirms why it is important to test and treat HIV early

Seven-in-ten people with HIV taking combined antiretroviral therapy for the first time recover their CD4 cell count to above 500 cells/mm3, French researchers report in AIDS. Having a higher CD4…

Focus on resistance to HIV offers insight into how to fight the virus

Global burden of TB: where we are and what to do

In The Lancet Infectious Diseases, the Global Burden of Disease Tuberculosis Collaborators report the burden of tuberculosis in 2016 and trends since 1990. A comment reflects on the results of…

Vaccines: our greatest hope in defeating AIDS, Ebola, TB, and other infectious diseases

Doctors, public health officials, and governments are facing what is now the second largest Ebola outbreak in history. The death toll from this latest outbreak in the northeastern region of…

UNAIDS report overlooks significant aspects of the global HIV response

29 November 2018: UNAIDS' World AIDS Day 2018 report is selectively silent on persistently high AIDS mortality and looming treatment rationing in light of donor disengagement. This year’s UNAIDS report highlights the…

80 adolescents a day will still die of AIDS by 2030, despite slowdown in epidemic

By 2030, around 80 adolescents will be dying of AIDS every day if “we don’t accelerate progress in preventing transmission,” the head of the United Nations Children’s Fund (UNICEF) said on Thursday…

Ending the HIV epidemic: where does Europe stand?

From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the…

BHIVA encourages universal promotion of Undetectable=Untransmittable (U=U)

In early 2016, the Undetectable=Untransmittable (U=U) consensus statement was launched by the Prevention Access Campaign. To date the campaign has been endorsed by more than 771 organisations from 95 different…